We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NDRAW market cap is 252.36k. The company's latest EPS is USD -1.1959 and P/E is -0.25.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.31M | -2.94M | -2.99M | -3.06M | -1.46M |
Net Income | -3.29M | -2.94M | -2.56M | -3.1M | -1.46M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -10.84M | -11.5M | -11.5M | -13.16M | -10.52M |
Net Income | -17.53M | -12.12M | -11.35M | -13.18M | -10.06M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 9.27M | 6.66M | 9.24M | 7.6M | 6.75M |
Total Liabilities | 2.07M | 2.16M | 2.31M | 2.41M | 1.1M |
Total Equity | 7.2M | 4.5M | 6.93M | 5.2M | 5.66M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 7.18M | 8.77M | 12.88M | 9.27M | 6.75M |
Total Liabilities | 2.42M | 1.6M | 2.09M | 2.07M | 1.1M |
Total Equity | 4.76M | 7.17M | 10.78M | 7.2M | 5.66M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -12.77M | -2.51M | -4.78M | -7.38M | -9.55M |
Investing | -203k | -27k | -27k | -27k | -25k |
Financing | 8.4M | N/A | 4.73M | 5.85M | 7.52M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -8.59M | -10.75M | -11.12M | -12.77M | -9.55M |
Investing | -44k | -75k | -45k | -203k | -25k |
Financing | 8.34M | 11.88M | 13.4M | 8.4M | 7.52M |
Market Cap | 252.36k |
Price to Earnings Ratio | -0.25 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.89 |
Price to Book Ratio | 0.45 |
Dividend Yield | - |
Shares Outstanding | 8.41M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.5 (98.06%) |
Company Name | ENDRA Life Sciences Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.endrainc.com |
Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions